Document is current
Any future updates will be listed below
-
Authors
Giugliano, Dario https://orcid.org/0000-0002-9377-873X
Scappaticcio, Lorenzo
Longo, Miriam
Caruso, Paola
Maiorino, Maria Ida https://orcid.org/0000-0003-4659-7546
Bellastella, Giuseppe
Ceriello, Antonio
Chiodini, Paolo
Esposito, Katherine
- License Information
-
More Information
Article History
Received: 8 July 2021
Accepted: 19 August 2021
First Online: 15 September 2021
Declarations
:
: Not applicable.
: Not applicable.
: D. G. received a consultancy fee from Eli Lilly and has held lectures for Eli Lilly, Boehringer Ingelheim, Novo Nordisk, Novartis, Mundipharma, Sanofi. M. I. M. has held lectures for Astrazeneca, Sanofi, NovoNordisk, and MSD. K. E. received a consultancy fee from Eli Lilly and has held lectures for Eli Lilly, Sanofi, and Novo Nordisk. A.C. has been an advisory board member for Abbott, Astra Zeneca, Boehringer Ingelheim, DOC Generici, Eli Lilly, Janssen, Mundipharma, Novo Nordisk and OM Pharma; has given lectures for Astra Zeneca, Berlin Chemie, Boehringer Ingelheim, Eli Lilly, Mundipharma, Novo Nordisk and Roche Diagnostics; and has received research grants from Astra Zeneca, Eli Lilly, Mitsubishi and Novartis. No other potential conflicts of interest relevant to this article were reported.
